AstraZeneca PLC (AZN)
65.05
-0.22
(-0.34%)
USD |
NASDAQ |
Nov 14, 16:00
65.00
-0.05
(-0.08%)
After-Hours: 20:00
AstraZeneca Non-Current Deferred Revenue (Quarterly)
Non-Current Deferred Revenue (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Non-Current Deferred Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| Date | Value |
|---|---|
| March 31, 2020 | -- |
| December 31, 2019 | -- |
| September 30, 2019 | -- |
| June 30, 2019 | -- |
| March 31, 2019 | -- |
| December 31, 2018 | -- |
| September 30, 2018 | -- |
| June 30, 2018 | -- |
| March 31, 2018 | -- |
| December 31, 2017 | -- |
| September 30, 2017 | -- |
| June 30, 2017 | -- |
| March 31, 2017 | -- |
| December 31, 2016 | -- |
Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years
Non-Current Deferred Revenue (Quarterly) Benchmarks
| GSK PLC | -- |
| Amgen Inc | -- |
| Johnson & Johnson | -- |
| Eli Lilly and Co | -- |
| Sanofi SA | -- |